|
|
Prepublished online as a Blood First Edition Paper on July 31, 2003; DOI 10.1182/blood-2003-04-1244.

Submitted April 24, 2003
Accepted July 22, 2003
Functional defects of dendritic cells in CD40-deficient patients
Stefania Fontana, Daniele Moratto, Surinder Mangal, Maria De Francesco, William Vermi, Simona Ferrari, Fabio Facchetti, Necil Kutukculer, Claudia Fiorini, Marzia Duse, Pranab K Das, Luigi D Notarangelo, Alessandro Plebani, and Raffaele Badolato*
Istituto di Medicina Molecolare, University of Brescia, Brescia, Italy
Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Istituto di Microbiologia, University of Brescia, Brescia, Italy
Cattedra di Anatomia Patologica, University of Brescia, Brescia, Italy
Department of Pediatrics, Ege University, The Medical School, Izmir, Turkey
Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Istituto di Medicina Molecolare, University of Brescia, Brescia, Italy
* Corresponding author; email: badolato{at}master.cci.unibs.it.
We have recently identified two patients with a rare autosomal recessive form of Hyper IgM disease, known as HIGM3, due to mutations in the CD40 gene. These patients presented opportunistic infections as observed in X-linked HIGM, suggesting that the CD40-CD40 ligand interaction is important for promoting T-cell mediated immunity. In order to evaluate whether innate immunity signals may substitute CD154 for inducing maturation of dendritic cells (DCs), we analyzed monocyte-derived DCs in these patients. Monocyte-derived DCs of HIGM3 subjects, upon ex vivo stimulation with TNF- or LPS combined with IFN- , normally express all the markers of mature DCs, such as CD83 and DC-LAMP. However, cell surface levels of HLA-DR in mature DCs are reduced, as is costimulatory activity of these cells for allogeneic naive T cells. In addition, CD40-deficient DCs secrete lower amounts of IL-12, but larger quantities of IL-10, in comparison to control subjects. Finally, analysis of circulating plasmacytoid DCs demonstrates a normal percentage of this subset in CD40-deficient cells, but IFN- secretion in response to HSV-1 infection is severely reduced in patients. These observations suggest that the severe impairment of DCs maturation may contribute to the defect of T-cell mediated immunity that is observed in HIGM3 patients.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. F. Skibola, A. Nieters, P. M. Bracci, J. D. Curry, L. Agana, D. R. Skibola, A. Hubbard, N. Becker, M. T. Smith, and E. A. Holly
A functional TNFRSF5 gene variant is associated with risk of lymphoma
Blood,
April 15, 2008;
111(8):
4348 - 4354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sitati, E. E. McCandless, R. S. Klein, and M. S. Diamond
CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus Encephalitis
J. Virol.,
September 15, 2007;
81(18):
9801 - 9811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Filipe-Santos, J. Bustamante, M. H. Haverkamp, E. Vinolo, C.-L. Ku, A. Puel, D. M. Frucht, K. Christel, H. von Bernuth, E. Jouanguy, et al.
X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production
J. Exp. Med.,
July 10, 2006;
203(7):
1745 - 1759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stasiolek, A. Bayas, N. Kruse, A. Wieczarkowiecz, K. V. Toyka, R. Gold, and K. Selmaj
Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis
Brain,
May 1, 2006;
129(5):
1293 - 1305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zhang, J. D. Lifson, and C. Chougnet
Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions
Blood,
March 1, 2006;
107(5):
1989 - 1995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Vermi, F. Facchetti, E. Riboldi, H. Heine, S. Scutera, S. Stornello, D. Ravarino, P. Cappello, M. Giovarelli, R. Badolato, et al.
Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma
Blood,
January 15, 2006;
107(2):
454 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Weiler and J. L. Bankers-Fulbright
Common Variable Immunodeficiency: Test Indications and Interpretations
Mayo Clin. Proc.,
September 1, 2005;
80(9):
1187 - 1200.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Lavelle, A. Jarnicki, E. McNeela, M. E. Armstrong, S. C. Higgins, O. Leavy, and K. H. G. Mills
Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent
J. Leukoc. Biol.,
May 1, 2004;
75(5):
756 - 763.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|